Clinical Trial Update: A follow-on Study to Assess Long-term Safety and Tolerability of i.c.v Administration of sNN0029 in Patients With ALS [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating the long-term safety and tolerability of intracerebroventricular administration of sNN0029 in patients with amyotrophic late…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• sNN0029

Snippet

Sponsor: Newron Sweden AB | Conditions: Amyotrophic Lateral Sclerosis | Phase 1 | Status: TERMINATED